title: Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders.
abstract: The aim of this study was to compare insulin sensitivity expressed by the hyperinsulinemic clamp and by the homeostasis model assessment (HOMA) and QUICKI indexes in subjects with various disorders influencing insulin action. We examined 41 type 2 diabetic patients, 20 insulinoma patients, 32 women with polycystic ovary syndrome, 16 patients with primary hyperaldosteronism, 12 patients with essential high renin hypertension, and 47 healthy subjects. The metabolic clearance rate of glucose and the insulin sensitivity index calculated from the clamps were compared with both the HOMA and QUICKI indexes. The relationship of insulin action to body mass index, serum cholesterol, and triglycerides as well as to systolic and diastolic blood pressures was also evaluated. Body mass index was very strongly associated with the insulin sensitivity index (r = -0.70; P < 0.0001) in the entire cohort of 168 subjects. Cholesterol, triglycerides, and blood pressure influenced insulin action in the healthy subjects and type 2 diabetic patients. A significant relationship was observed between the insulin sensitivity index and the HOMA or QUICKI indexes in healthy subjects (r = -0.66; P < 0.0001), type 2 diabetic patients (r = -0.68; P < 0.0001), and women with polycystic ovary syndrome (r = -0.65; P < 0.0001). We did not find any relationship between the above variables in the patients with insulinoma or primary hyperaldosteronism. The HOMA and QUICKI indexes do not offer the same information as glucose clamps in the rare cases with differently impaired peripheral or hepatic insulin action.
authors.affiliation: Third Department of Internal Medicine, First Faculty of Medicine, Charles University, 128 08 Prague 2, Czech Republic. jan.skrha@lf1.cuni.cz
authors.forename: Jan
authors.initials: J
authors.lastname: Skrha
authors.forename: Tomás
authors.initials: T
authors.lastname: Haas
authors.forename: Gustav
authors.initials: G
authors.lastname: Sindelka
authors.forename: Martin
authors.initials: M
authors.lastname: Prázný
authors.forename: Jirí
authors.initials: J
authors.lastname: Widimský
authors.forename: David
authors.initials: D
authors.lastname: Cibula
authors.forename: Stepán
authors.initials: S
authors.lastname: Svacina
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001794:Blood Pressure; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D004700:Endocrine System Diseases / Q000503:physiopathology*; D005260:Female; D015309:Glucose Clamp Technique; D006706:Homeostasis; D006801:Humans; D006929:Hyperaldosteronism / Q000503:physiopathology; D006973:Hypertension / Q000503:physiopathology; D007328:Insulin / Q000097:blood* / Q000494:pharmacology*; D007333:Insulin Resistance; D007340:Insulinoma / Q000503:physiopathology; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000503:physiopathology; D011085:Polycystic Ovary Syndrome / Q000503:physiopathology; D014280:Triglycerides / Q000097:blood
chemical_list: D007328:Insulin; D014280:Triglycerides; D002784:Cholesterol